Heart Failure New York Heart Association (NYHA) Class II

1

Review clinical trials related to Heart Failure New York Heart Association (NYHA) Class II. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PrEcision Pacing in HFpEF: the PEP-HFpEF Trial

The PEP-HFpEF study is a prospective, single-center mechanistic study evaluating personalized heart rate pacing (myPACE) in patients with heart failure with preserved ejection fraction (HFpEF) and existing cardiac physiologic pacemakers. Participants will undergo sequential periods of standard and personalized pacing with serial physiologic assessments to evaluate the effects of myPACE on exercise capacity, cardiac function, biomarkers, quality of life, and clinical outcomes.

Participants needed: 36
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Tufts Medical CenterUpdated: Oct 8, 2026Locations: 1
Eligibility criteria

Age ≥18 years. [+7]

Age <18 years. [+7]